| Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapse. | |
| | |
MedLine Citation:
|
PMID: 21691208 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND AND AIMS: We completed a retrospective analysis of patients with genotype 3 hepatitis C virus (HCV) undergoing therapy in four UK centres with large populations of patients from the Indian subcontinent. MATERIALS AND METHODS: Notes on all patients treated with pegylated interferon and ribavirin were reviewed and factors that influenced the response were examined. RESULTS: Six hundred and four patients with genotype 3 HCV were studied, of whom 299 were Asians. Median age was 43 years, 65% were men and 24% had cirrhosis. Overall, 457 (76%) patients achieved sustained virological response (SVR). By multivariable analysis it was found that ethnicity was not associated with an impaired response but age, cirrhosis and diabetes were significantly associated with a reduced SVR, the likelihood of a response was reduced by 25% per 10-year increment in age, by 59% among individuals with cirrhosis and by 62% among individuals with diabetes mellitus. Most patients who did not achieve an SVR relapsed (15%) rather than failing to achieve an end of treatment response. CONCLUSION: The response to antiviral therapy in genotype 3 HCV is not affected by South Asian (vs. Caucasian) ethnicity, but age, cirrhosis and diabetes reduce the response. Treatment failure most often is due to relapse. |
| | |
Authors:
|
Dania Shoeb; Ian A Rowe; Dennis Freshwater; David Mutimer; Ashley Brown; Sulleman Moreea; Ruchit Sood; Richard Marley; Caroline A Sabin; Graham R Foster |
Related Documents
:
|
19259078 - Seroprevalence of chronic hepatitis b virus infection among taiwanese human immunodefic... 18761958 - Prevalence of hepatitis c and hepatitis b infection in the hiv-infected population of f... 17221128 - Serological markers and risk factors for hepatitis b and c viruses in patients infected... 16410888 - Seroprevalence of hepatitis b and c in brazilian army conscripts in 2002: a cross-secti... 19259078 - Seroprevalence of chronic hepatitis b virus infection among taiwanese human immunodefic... 3286508 - Persistence of yersinia enterocolitica in man. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-17 |
Journal Detail:
|
Title: European journal of gastroenterology & hepatology Volume: - ISSN: 1473-5687 ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9000874 Medline TA: Eur J Gastroenterol Hepatol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
aThe Liver Unit, Blizard Institute for Cellular and Molecular Science, Queen Mary University of London bThe Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham cSt Mary's Hospital, Imperial College London dBradford Teaching Hospitals Foundation Trust, Bradford eResearch Department of Infection and Population Health, University College London Medical School, Royal Free Campus, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontar...
Next Document: Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers.